Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Calcium carbonate + lansoprazole) by Addpharma for Reflux Esophagitis (Gastroesophageal Reflux Disease): Likelihood of Approval
(Calcium carbonate + lansoprazole) is under clinical development by Addpharma and currently in Phase I for Reflux Esophagitis (Gastroesophageal Reflux...